UNSPSC 51181606: Propylthiouracil

This classification denotes an antithyroid agent with the molecular formula C7H10N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 721M9407IY, chemically known as 2,3-dihydro-6-propyl-2-thioxo-4(1h)-pyrimidinone but generally known as propylthiouracil, which bears US NIH Compound Identifier 657298. European Medicines Agency schedules Propylthiouracil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10123MIG. The term PROPYLTHIOURACIL is an International Non-Proprietary Name.

UNSPSC 51181606 Propylthiouracil is a Commodity code covering a specific pharmaceutical active ingredient used in the treatment of hyperthyroidism and thyroid conditions. State and local governments procure this drug primarily through health departments, corrections departments, and public hospital systems to treat inmates, patients in custody, and indigent populations requiring thyroid management. The solicitations under this code reflect demand from state Medicaid programs and corrections facilities that source medications through centralized pharmaceutical procurement channels or group purchasing organizations.

The source material provides no recent state and local contract opportunities tagged to this code, leaving the geographic distribution and issuing-body concentration unclear. Without posted solicitations to reference, the current market activity and procurement frequency cannot be characterized. Business development professionals should monitor state health department RFQs, corrections department ITBs, and cooperative-purchasing pharmaceutical contracts for this active ingredient, particularly in states with large corrections populations or high Medicaid enrollment, though recent posted opportunities under this specific UNSPSC number are not evident in available records.